Thu, Nov 9, 8:09 AM, Zacks
VIVUS (VVUS) Q3 Loss Narrows, Qsymia Falters, Shares Down
VIVUS (VVUS) reported third-quarter results wherein it reported narrower-than- expected loss. However, Qsymia sales fell from the year-ago period.
Thu, Sep 28, 7:25 AM, Zacks
Orexigen's (OREX) Contrave Sales Improving on Promotions
Despite competition, Orexigen Therapeutics (OREX) obesity drug, Contrave has performed well so far this year driven by the company's promotional strategies.